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Trends
Ataxin 2 (ATXN2) orthologs containing
Lsm, PAM2, and PRD motifs are now
identified from man to yeast and
plants.
Global growth repression in stress per-
iods by ATXN2 via inhibition of
mTORC1 phosphorylation signals
was recently shown in yeast, worms,
and man.
Compensatory breakdown of lipids via
ATXN2 was observed in worms, flies,
and mammals.
Both effects are modulated by specific
mitochondrial matrix enzymes (e.g.,
IVD, ACADS) under the control of
ATXN2. Factors responsible for elim-
ination of dysfunctional mitochondria
and bacteria (e.g., PINK1) are also
governed by ATXN2, so it may have
contributed to eukaryotic origin.
Depletion of ATXN2 levels is neuropro-
tective in ALS and in SCA2 [258_TD$DIFF]mouse
models; this confirms previous obser-
vations in yeast and flies.
1Department of Neurology, Goethe
University Medical School, 60590
Frankfurt am Main, Germany
2Max Planck Institute for Molecular
Genetics, Ihnestrabe 63-73, 14195
Berlin, Germany
3Suna and _Inan Kiraç Foundation,
Neurodegeneration Research
Laboratory (NDAL), Bogaziçi
University, 34342 Istanbul, TurkeyReview
Efficient Prevention of
Neurodegenerative Diseases
by Depletion of Starvation
Response Factor Ataxin-2
Georg Auburger,1,* Nesli-Ece Sen,1 David Meierhofer,2
Ayşe-Nazli Başak,3 and Aaron D. Gitler4
Ataxin-2 (ATXN2) homologs exist in all eukaryotic organisms and may have
contributed to their origin. Apart from a role in endocytosis, they are known for
global effects on mRNA repair and ribosomal translation. Cell size, protein
synthesis, and fat and glycogen storage are repressed by ATXN2 via mTORC1
signaling. However, specific liver mitochondrial matrix enzymes and the
mitochondrial repair factor [257_TD$DIFF]PINK1 require ATXN2 abundance. During periods
of starvation, ATXN2 is transcriptionally induced and localized to cytosolic
stress granules, where nuclear factors dock to compensate RNA pathology.
These physiological actions were now revealed to be crucial for human
neurodegenerative diseases, given that ATXN2 depletion is surprisingly
efficient in preventing motor neuron and cerebellar atrophy, as demonstrated
in mouse models, flies, and yeast.
Introduction
Age-associated human diseases are a major burden for developed society. The underlying
factors include environmental stressors and hereditary vulnerabilities. Whether toxic life events
repeatedly overwhelm the defense capacity of an organism will depend on specific genes and
their variation as well as on nutrient availability and stored energy. In particular, with the
domestication of endosymbionts of bacterial origin, namely, mitochondria and chloroplasts,
it must have become important for eukaryotic cells to expand their genetic machinery to
compensate the deleterious consequences of chronic oxidative stress and carbohydrate/lipid
depletion. The repair of fragile single-stranded RNA had to be ensured, and the recruitment of
alternative fuels from storage [259_TD$DIFF]needed to bemanaged. Besides, cell growth had to be repressed
during periods of excessive bioenergetic demands or of nutrient starvation. The chronic
dysregulation of these processes would prominently affect cells with high rates of mitochondrial
respiration such as neurons, which cannot undergo cell division and will insidiously accumulate
the deleterious consequences during the organism’s life span. Ataxin-2 (human gene symbol
ATXN2) is now emerging as a key factor for human neurodegenerative diseases, and it appears
to act within this machinery of nutrient disposal and damage repair.
Ataxin-2 Homologs in Phylogenesis
During phylogenetic evolution, a protein with a combination of domains similar to ATXN2 was
never found among prokaryotes, but it appears in every eukaryotic organism, irrespective of
whether it contains mitochondria or chloroplasts. Land plants have several copies of the geneTrends in Neurosciences, August 2017, Vol. 40, No. 8 http://dx.doi.org/10.1016/j.tins.2017.06.004 507
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(G. Auburger).family (CID3/CID4 in Arabidopsis thaliana), with each plant species having at least one copy.
Yeast strains contain one copy (PBP1 in Saccharomyces cerevisiae), while vertebrate animals
have two copies, except birds [1]. The complete gene family targets RNAs to adapt cells to
rapid environmental changes [2].
[260_TD$DIFF] he conserved protein structure [261_TD$DIFF]of ATXN2 homologs is composed of three elements: First, it
contains a PAM2 motif toward the C terminus, which mediates direct protein interaction with
the cytosolic poly(A)-binding protein PABPC1, and thus the association with the 30-untrans-
lated region of all mRNAs during ribosomal translation in periods of cell growth, or its
association with these mRNAs in stress granules in periods of stalled translation and RNA
quality control [3,4]. Second, toward the N terminus it contains an Lsm (like Sm) domain and an
Lsm-associated domain [262_TD$DIFF](LsmAD), implicated in the cytosolic refolding andmaturation of a wide
spectrum of RNAs and [263_TD$DIFF]in their degradation. Apparently, this triggers a preferential interaction of
Ataxin-2 with uridine-rich cis-regulatory elements in the 30-untranslated region of specific
mRNAs, such as the growth-associated AU-rich elements [5]. Third, it commonly contains
proline-rich domains [264_TD$DIFF](PRD), which are known to mediate the association with the receptor
endocytosis apparatus and influence the trophic state of cells [6,7]. In this way, mammalian
ATXN2 interacts with GRB2 and endophilin-A, presumably influencing both the clathrin-
independent fast-acting endocytosis and the dendritic spinemorphogenesis of neurons [8–10].
It is interesting to note that a polyglutamine (polyQ) domain (encoded by a CAG repeat) is
present only among primates and among insects [1]. The unstable expansion of this repeat in
humans causes an age-associated multisystem neural atrophy with preferential affection of
motor neurons, cerebellar [265_TD$DIFF]Purkinje neurons, and basal ganglia neurons including the thalamus
[11,12]. This condition was termed as ‘spinocerebellar ataxia type 2 (SCA2)’, and thus provided
the name for Ataxin-2.
Influence of Ataxin-2 on mRNA Translation
Apparently, ATXN2 is needed to counteract starvation, given that it is transcriptionally induced
in human and mouse cells that are deprived of glucose, amino acids, and lipid-containing
serum [13]. During periods of low glucose levels, oxidative stress, overheating, or viral infection,
yeast PBP1 and the other members of the ATXN2 protein family will relocalize together with its
interactor poly(A)-binding protein to cytosolic stress granules, where the repair of RNAs occurs
and their decay is decided [13,14]. This cellular damage compensation effort occurs in
interaction with several other RNA-binding proteins that are relocalized from the nucleus to
stress granules, such as TDP-43, FUS, or TIA-1, and this seems essential for the long-term
health of neurons [15–21]. Gene redundancy in mammals is ensured by another homolog,
which was termed Ataxin-2-like (ATXN2L) or Ataxin-2-related protein (A2RP), but it lacks the
polyQ domain. It has a stronger association with the nucleus than ATXN2 in periods of health,
also relocalizes to stress granules during arsenite or heat treatment, and is able to
heterodimerize with ATXN2 [22–25].
Effects of ATXN2 on mRNA translation were first established as the cause of conspicuous
phenotypes in several species. Ambivalent evidence emerged that it acts as a global
translational repressor in stress periods, as would be expected from a component of stress
granules, and also as a translational enhancer of specific mRNAs in growth periods, as
expected in view of its association with polysomes. The absence of its ortholog ATX-2 in
the nematode Caenorhabditis elegans leads to abnormal masculinization of the germ line via
insufficient translation of specific factors, [266_TD$DIFF]for example, the rme-2 mRNA that is controlled by
MEX-3 and GLD-1, an ortholog of the myelination factor QKI [26]. In Drosophila melanogaster
flies, its ortholog dATX2 causes actin-dependent phenotypes together with female sterility [27].
Similarly, its suppression in flies causes an altered circadian rhythm via insufficient translation of508 Trends in Neurosciences, August 2017, Vol. 40, No. 8
the clock-component PERIOD via LSM12–TYF interaction [28–30], with some circadian
phenotypes also detectable in Atxn2-knockout mice [31], but at the same time it mediates
an opposite silencing effect on NOT1 via DDX6/ME31B interaction [30]. Initial findings showed
the global translation rate of mouse cells with ATXN2 deficiency to be reduced and suggested
ATXN2 to act as global translation activator. However, these experiments involved a starvation
period followed by maximal growth stimuli, so unresolved RNA damage may have reduced
translation rates [13,32]. It is important to consider that the deletion of yeast PBP1 suppresses
the lethality due to deletion of the global translation activator PAB1, the poly(A)-binding protein
[33]. This indicates the importance of PBP1/ATXN2 and suggests that it acts as an inhibitor of
global mRNA translation. Indeed, the global effect of ATXN2 on growth seems to be repressive,
given that body size, cell size, and nutrient storage increase after ATXN2 depletion [34,35]. A
role of ATXN2 as translation suppressor for specific targets was also reported, since the
expression of a Ca2+[256_TD$DIFF]/calmodulin-dependent protein kinase II translational reporter was
increased by the knockdown of dATX2 [36]. In worms, ATX-2 depletion impedes microtubule
growth and nuclear cytokinesis, via direct protein interaction with the prion[267_TD$DIFF]-like protein SZY-20,
so centrosome size is inversely correlated with ATX-2 abundance [37,38]. These data may
explain why ATXN2-depleted cells with excess nutrients increase in size instead of entering
proliferation.
Other ATXN2 protein interactors also contain RNA-binding domains, and thus underscore its
importance for RNA processing and brain diseases: (i) The Ataxin-2 binding protein 1 (A2BP1 or
RBFOX1) is a nuclear splicing factor that modifies neuronal excitability and was implicated in
autism [39–41]. (ii) The DEAD/H-box RNA helicase DDX6 as a component of stress granules
and P-bodies associates with ATXN2 and with ATXN2L to modulate mRNA storage in periods
of stalled translation as well as the degradation of mRNAs [3,22,42]. (iii) The FMRP protein,
whose mutations are responsible for the fragile X mental retardation syndrome, associates with
polysomes and interacts with ATXN2 for olfactory habituation in a process that involves the
microRNA pathway and synaptic plasticity [36,43] (Figure 1).
Modulation of Growth in Stress Periods by Ataxin-2 Occurs via mTORC1
Signaling
It was now shown that ATXN2 acts as a repressor of mechanistic target of rapamycin (mTOR)
signaling in mouse fibroblasts and human neural cells, thus blocking protein biosynthesis and
cell growth in times of bioenergetics deficit [13]. It is still a matter of controversy how this is
achieved precisely. In yeast, a transient sequestration of the mTORC1 ortholog TOR1 to stress
granules in periods of excessive heat is observed, which is prevented by PBP1 deletion and
driven by PBP1 overexpression. This was confirmed by a coimmunoprecipitation experiment,
indicating a direct interaction between an overexpressed N-terminal PBP1 fragment and TOR1
[44]. This TOR1 sequestration occurs in response to a PBP1 phosphorylation by the PAS
domain containing serine/threonine kinase PSK1, itself regulated via phosphorylation by the
AMP kinase ortholog SNF1 as a response to low energy levels [45]. A slightly different scenario
has been proposed in C. elegans, where ATX-2 also suppressed mTOR signals, but in an
indirect manner via associationwith a component of the tuberous sclerosis complex [34]. These
data from two model organisms agree with findings in mammalian cells that the functions of
ATXN2 and ATXN2L are governed by phosphorylation events [46]. In addition, recent data
suggest that ATXN2 affects cell growth via several downstream phosphorylation cascades, as
repressors of mTOR and phosphoinositide 3-kinase signals and as enhancers of PINK1 kinase
[13,47]. Thus, ATXN2 is centrally placed within phosphorylation cascades that control the
trophic state of cells, particularly mRNA translation, lipid signals, and autophagy.
Many lines of evidence suggest that Ataxin-2 family members play a role in starvation-induced
autophagy, in view of their interaction with growth factor receptor endocytosis and signalingTrends in Neurosciences, August 2017, Vol. 40, No. 8 509
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Figure 1. ATXN2 Protein Features with Interaction Targets. Direct association of ATXN2 with proteins and mRNA targets under physiological conditions at the
ribosomal translation apparatus and at the endocytosis machinery differs from interactions with stress granule components in periods of starvation and oxidative stress,
and during accumulation and aggregation. The polyQ domain has strong hydrophilicity and surface probability, so its expansion probably alters the conformation, with
consequences of decreased solubility and aggregation of the entire protein, in parallel to aberrant interaction with ITPR1. Among the four PRDs, the N-terminal and
central domains show best experimental interaction. A superstructure of alpha, beta, and coil regions is not apparent.[6,7,48], with the AMP kinase ortholog SNF1 [45], with mTOR signaling [13], and with PINK1
[47], all of them being known coordinators of the macroautophagic pathway. These global
repressive effects on growth may explain [268_TD$DIFF]several indirect effects of ATXN2 on diverse
pathways, simply as consequences of general transcription and translation rates. For example,
PBP1 is a modifier of the average poly(A)-tail length of mRNAs, which is controlled by
deadenylases and depends on translational activity [5,49]. Similarly, deficiency in PBP1 or
ATXN2 leads to accumulation of nuclear RNA–DNA hybrids, a process that is repressible by
Mg2+, dependent on RNaseH1, and can be counteracted by calorie restriction [50]. RNA–DNA
hybrids appear as by-products of normal transcriptional activity, so an increase in their number
may simply reflect the increased size of ATXN2-depleted cells. Consequently, dATX2 enhances
another PAS domain containing factor, the circadian rhythm factor PER [28,29], which triggers
the general repression of metabolism and protein synthesis during nighttime (Figure 2).
Ataxin-2 Effects on Nutrients and Life Span Are Mediated by Which mRNA
Targets?
In patients with SCA2, a depletion of subcutaneous fat stores is evident before the first
subjective complaints and objective signs of motor deficits appear. Conversely, in mice with
ATXN2 deficiency, the overall phenotypes are due to an accumulation of hepatic/gonadal/
intestinal/subcutaneous fat and of glycogen in liver granules, with the consequence of obesity,
dyslipidemia, insulin resistance, and infertility [48]. In D. melanogaster, the knockdown of
dATX2 exclusively in the larval fat body leads to reduced growth and elevated death of the
flies during development, presumably due to inadequate lipid breakdown [51]. Similarly, in510 Trends in Neurosciences, August 2017, Vol. 40, No. 8
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Figure 2. Evolution of ATXN2 Functions. Yeast, worm, fly, andmammalian evidence supports the roles of ATXN2 for RNA translation at ribosomes and RNA repair
at stress granules, for the suppression of global protein synthesis via mTORC1, for the storage of fat/glycogen, and for fuel breakdown at mitochondria in periods of
excessive bioenergetic demands. TCA, tricarboxylic acid.C. elegans it was recently shown that fat content of dietary-restricted worms increases by ATX-
2 deficiency [34]. Consistently, these results underline the key role of Ataxin-2 in the recruitment
of stored reserve fuels.
The identity of some mRNAs that are controlled by ATXN2 to mediate all these effects was
revealed in several publications over the past two years, and interestingly a large part of them
encode mitochondrial precursor proteins or control the cytosolic breakdown of stored fuels.
The investigation of the global transcriptome of mouse brain with ATXN2 deficiency revealed a
marked reduction in the mRNA levels of isovaleryl dehydrogenase as a mitochondrial matrix
enzyme crucial for the breakdown of the amino acid leucine, and of several factors associated
with the endoplasmic reticulum [52], in parallel to an increase in the mRNA levels of several
components of the translation machinery [32]. Leucine levels are a determinant of mTORC1
signaling and protein synthesis [53]. Profiling efforts of the global proteome and metabolome of
mouse brain and liver with ATXN2 deficiency confirmed the substantial decrease in the levels of
isovaleryl dehydrogenase (to 7% upon quantitative immunoblots in liver) and of other
mitochondrial matrix enzymes that degrade short fatty acids and branched chain amino acids,
such as ACADS, ALDH6A1, ALDH7A1, MCCC2, PCCA, and OTC. In addition, decreased
levels were also demonstrated for components of the mitochondrial citric acid cycle [54].
Another study defined the global proteome profile of yeast with PBP1 deletion without or withTrends in Neurosciences, August 2017, Vol. 40, No. 8 511
stress from NaN3 or heat administration, again detecting significant downregulations of
bioenergetics key enzymes, such as KGD2 (a component of the mitochondrial alpha-
ketoglutarate dehydrogenase complex) and CIT1 (the rate-limiting enzyme of the mitochondrial
citric acid cycle) in the absence of stress, together with reduced levels of the stress granule
component GIS2 during heat or NaN3 stress [55]. Interestingly, it was also shown that a
reduction of several eisosome proteins, involved in fast endocytosis, occurs as a consequence
of PBP1 deletion during stress [55]. Thus, in parallel to the repression of global protein synthesis
during stress periods, it requires ATXN2 to maintain normal levels of specific mitochondrial
precursors.
Moreover, yeast PBP1 is crucial to rescuemitochondrial dysfunction. A recent genomemodifier
survey studied cells with a mitochondrial dysfunction that diminishes the proton gradient and
impairs the import of nuclear-encodedmitochondrial precursor proteins. The cell death of these
cells was shown to occur by cytosolic overaccumulation of the precursors; this toxicity could be
rescued by overexpression of (i) the stress granule components GIS2 and PBP1, (ii)
components of the cytosolic ribosomal translation apparatus, (iii) modifiers of mTOR growth
signals, or (iv) the RNA processing machinery [35]. Therefore, an ATXN2-mediated repression
of mTOR and global protein synthesis would seem to be the plausible mechanism to prevent
mitochondrial precursor overaccumulation stress. Previously, it had been shown that the
viability of yeast cells lacking mitochondrial DNA depends on altered mitochondrial import
and can be modified by mutations of cytosolic PBP1 [56]. The effects of ATXN2 on stressed
mitochondria were also confirmed in patient blood, mouse tissue, and human neural cells,
where it was shown to enhance the mRNA levels of PINK1 [47], a mitochondrial quality control
factor whose absence triggers precursor import deficits [57]. ATXN2 also enhances the levels of
OPA1 [47], a crucial factor for mitochondrial repair by fusion, whose mutation triggers an
autosomal dominantly inherited neurodegenerative process of the optic nerve [58]. It is relevant
to note that ATXN2 dysfunction leads to dysregulated calcium homeostasis in neurons; this
might also be due to mitochondrial dysfunction, not only to the proposed pathology at the
endoplasmic reticulum by interaction of accumulated expanded ATXN2 with ITPR1 [52,59].
Curiously, within the first 100 N-terminal amino acids of the reference sequence of human
ATXN2, a mitochondrial targeting motif is predicted by some algorithms and indeed this
recombinant fragment localizes to mitochondria (unpublished observation), but current
research suggests the start methionine codon of ATXN2 to lie beyond this sequence [60],
and indeed the subcellular localization, fractionation, and cosedimentation studies of full-length
ATXN2 have never detected a mitochondrial association even under stress conditions [4,13].
Overall, ATXN2 emerges as a key cytosolic factor that modifies mitochondrial energy produc-
tion and health. Given that it governs the mitochondrial usage of fuels stored in the cytosol and
that it controls the repair and elimination of dysfunctional mitochondria via PINK1, the ATXN2
protein family throughout eukaryotic evolution may have contributed to the domestication of
endosymbionts.
Gain-of-Function versus Loss-of-Function, Neural Atrophy versus Metabolic
Excess and Cancer
The gain-of-function of ATXN2 triggered by unstable expansion of the polyQ domain with
subsequent protein aggregation always results in neural atrophy, affecting different neuronal
projections in dependence on severity. The normal size of the polyQ domain contains 22–23
successive glutamines, encoded by the nucleotide sequence (CAG)8CAA(CAG)4CAA(CAG)8–9.
Intermediate expansions of ATXN2 (Q27–33) trigger a degeneration of motor neurons, with the
clinical picture of amyotrophic lateral sclerosis (ALS) and appearance of cytosolic TDP-43
inclusion bodies [18,61,62]. Depending on either the presence of CAA interruptions or the
presence of modifier genes from Asian background, intermediate expansions of ATXN2 were
repeatedly observed in Chinese individuals affected by Parkinson’s disease with preferential512 Trends in Neurosciences, August 2017, Vol. 40, No. 8
degeneration of dopaminergic midbrain neurons [63,64]. Large polyglutamine expansions in
ATXN2 (Q34) result in the multi [269_TD$DIFF][253_TD$DIFF]-system-atrophy of neural tissue, which became known as
‘SCA2’ and shortens life span to about 15 years from clinical manifestation to death [65,66].
Clinical and neurophysiological evidence in individuals at the prodromal stage of SCA2
suggests that demyelination is a relatively early feature in this neurodegenerative disorder
[67,68].
Conversely, depletion of ATXN2 in mouse triggers obesity, dyslipidemia, and insulin resistance,
in a combination of findings that is typical of the human metabolic excess syndrome [48]. It is
important to note that genetic variants at the chromosomal locus of human ATXN2 are
associated with abnormal metabolism of lipids and carbohydrates and also carry a risk for
obesity, hypertension, and diabetesmellitus, thus acting as relevant genetic modifiers for the life
span of centenarians [69,70]. Children with extreme early onset obesity were found to display
an association with expansions and single-nucleotide polymorphism alleles within ATXN2 [25].
In an Egyptian family with ATXN2 polyQ expansion (several patients with Q39–52), it was noted
that the affected individuals at midstages of disease exhibited increased consumption of all
types of food with concomitant obesity and presented skin fat deposits in the absence of
altered blood lipid profiles; at prefinal stages they manifested reduced swallowing and weight






















































































Figure 3. ATXN2 Effects on Diverse Subcellular Compartments. A coordinate stress response recruits nuclear factors for RNA repair and stored cytosolic fuels,
triggering modifications of mRNA translation, mitochondrial function, lysosome-associated mechanistic target of rapamycin (mTOR) signals, actin-dependent vesicular
trafficking, and nuclear cytokinesis, to compensate damage and to adapt cell growth. EGFR, epidermal growth factor receptor; eIF, Eukaryotic initiation factor; TCA,
tricarboxylic acid.
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Outstanding Questions
By which enzymes does ATXN2
regulate glycogen breakdown in
periods of glucose depletion?
How does ATXN2 recruit lipids from
subcutaneous adipocytes and from
lipid droplets during stress?
What cargoes are endocytosed and
which growth factor receptors are
controlled by ATXN2?
Which protein domains and what
specific adaptor molecules mediate
the effects of ATXN2 on the actin
cytoskeleton?
Do selective mRNA and microRNA
targets of ATXN2 exist, beyond the
general quality control?
Can we identify a specific domain
within ATXN2 that is responsible for
mTORC1 repression?
Given that many mammalian orthologs
of yeast SNF1 and PASK exist, what
are the key factors upstream from
ATXN2 and how are they responding
to Ataxin-2 mutations?
Is the role of ATXN2 in autophagy
obvious?
Does ATXN2 also influence nuclear
constitutents, further confirming its
role in eukaryotic origin?
Will components of specific pathways,
which are sequestrated into the
cytoplasmic aggregates of polyQ-
expanded ATXN2, provide clues to
preventive therapy of SCA2 and ALS?
Are the neuroprotective effects of
Ataxin-2 deficiency selective for motor
neurons and cerebellar Purkinje
neurons, or does ATXN2 also influence
pathology in dopaminergic midbrain
neurons and in neurons of the cerebral
cortex, which are primarily responsible
for Parkinson’s disease and
Alzheimer’s dementia?
Do circadian rhythms modulate
ATXN2 production?
The role of ATXN2 in obesity and
insulin resistance – is it a relevant
therapeutic target?hypothalamus acts as the central regulator of food intake and body weight [72]. The clinical
course thus suggests mutant ATXN2 initially to be deficient in mTORC1 repression, while the
prefinal progressive accumulation of ATXN2 aggregates leads to excessive mTORC1
repression (Figure 3).
Therapeutic Suitability of Ataxin-2 Regulation
Ataxin-2 was proposed as a general modifier gene for neurodegenerative processes, when a
first compendium of modifiers on the basis of experimental evidence in the organisms
D. melanogaster, C. elegans, and S. cerevisiae was assembled [73]. The findings so far show
that ATXN2 overexpression potentiates the severity of atrophy in models of TDP-43-triggered
ALS, SCA1, SCA3, and tauopathies [18,74–76], while the deficiency of ATXN2 postpones the
pathology and reduces progression rate at least in the first two disorders [18,74,77]. In the case
of an ALSmouse model with a life span below 30 days, it was recently revealed that the genetic
ablation of ATXN2 may extend life span to over 300 days. This was accompanied by reduced
confluence of stress granules, and by reduced insolubility of the nuclear RNA-binding protein
TDP-43, whose abnormal deposition in cytosolic aggregates is a pathological hallmark of motor
neurons in ALS. Intriguingly, a significant rescue of survival was also achieved through ATXN2
knockdown via antisense oligonucleotides [77]. This technical approach was also successful in
reducing the toxic overactivity of ATXN2 in a mouse model of SCA2 [78], providing proof-
of-principle that preventive therapy for patients is now within reach. It is presently unclear to
what degree this neuroprotective effect of ATXN2 depletion can also be applied to Parkinson’s
disease and Alzheimer’s disease.
Conversely, the modulation of Ataxin-2 abundance also seems to be a potent modifier of tumor
growth, since it was shown that the spontaneous regression in about 10% of childhood
neuroblastoma tumors coincides with the upregulation of Ataxin-2 expression. Therefore,
recombinant overexpression could be successfully applied to drive neuroblastoma cells into
apoptosis [79].
It will be compelling to explore if the regulation of ATXN2 function via phosphorylation can be
indeed targeted by drugs in man, which would be widely applicable in the treatment of neural
atrophy, metabolic excess syndrome, and cancer.
Concluding Remarks
Depletion of ATXN2 is an unexpectedly efficient way to prevent and mitigate the atrophy of
motor neurons and cerebellar Purkinje cells in animal models of ALS and SCA2, making
experimental therapy of patients imminent. The physiological roles of ATXN2 in all eukaryotic
organisms, which may have initially contributed to the domestication of endosymbionts, are
diverse, but recent advances have defined its crucial function among stress responses. It is
critical to recruit stored lipids and glycogen in periods of low glucose availability and of high
energy demands, maintaining their breakdown in mitochondria. Furthermore, it promotes
stress granule formation to repair damaged RNAs, while repressing ribosomal mRNA transla-
tion and restricting cell growth. It serves as a central hub within phosphorylation cascades,
responding to activation signals from AMP kinase, inhibiting mTOR kinase, and promoting
PINK1 kinase. Probably, it further influences the initiation of autophagy. Future investigations
will focus on ATXN2 activity regulations and the redundancy with its homolog ATXN2L, to not
only advance neuroprotective treatments, but also to modulate the metabolic excess syn-
drome and cancer (see Outstanding Questions).
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Could tumor suppression be achieved
by ATXN2 gain of function in any type
of cancer?
Is it possible to define phosphorylation
sites that control localization, interac-
tions, and activity of ATXN2 and that
may become useful drug targets?
To what degree does ATXN2L com-
pensate for ATXN2, and which distinct
targets does it have?Disclaimer Statement
The authors declare no conflict of interest.
Acknowledgments
This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG AU96/11-3, 13-1, 14-1 and KR
1949/3-1) and from the EU project EuroSCA (LSHM-CT-2004-005033). It was also funded by the Neurology Clinic of the
Goethe University Frankfurt am Main, the Max Planck Society, the Prof. Dr. Dieter Platt Stiftung, Bogaziçi University
Research Funds, and the Suna and _Inan Kiraç Foundation.
ReferencesWould the manipulation of ATXN2
orthologs in plants and other food-
related microorganisms increase car-
bohydrate and lipid content, growth,
cell size, fertility, and stress
resistance?1. Jimenez-Lopez, D. and Guzman, P. (2014) Insights into the
evolution and domain structure of Ataxin-2 proteins across eukar-
yotes. BMC Res. Notes 7, 453
2. Jimenez-Lopez, D. et al. (2015) Evolutionary history exposes
radical diversification among classes of interaction partners of
the MLLE domain of plant poly(A)-binding proteins. BMC Evol.
Biol. 15, 195
3. Nonhoff, U. et al. (2007) Ataxin-2 interacts with the DEAD/H-box
RNA helicase DDX6 and interferes with P-bodies and stress
granules. Mol. Biol. Cell 18, 1385–1396
4. van de Loo, S. et al. (2009) Ataxin-2 associates with rough
endoplasmic reticulum. Exp. Neurol. 215, 110–118
5. Yokoshi, M. et al. (2014) Direct binding of Ataxin-2 to distinct
elements in 30 UTRs promotesmRNA stability and protein expres-
sion. Mol. Cell 55, 186–198
6. Nonis, D. et al. (2008) Ataxin-2 associates with the endocytosis
complex and affects EGF receptor trafficking. Cell. Signal. 20,
1725–1739
7. Drost, J. et al. (2013) Ataxin-2 modulates the levels of Grb2 and
SRC but not ras signaling. J. Mol. Neurosci. 51, 68–81
8. Boucrot, E. et al. (2015) Endophilin marks and controls a clathrin-
independent endocytic pathway. Nature 517, 460–465
9. Renard, H.F. et al. (2015) Endophilin-A2 functions in membrane
scission in clathrin-independent endocytosis. Nature 517, 493–
496
10. Yang, Y. et al. (2015) Endophilin A1 regulates dendritic spine
morphogenesis and stability through interaction with p140Cap.
Cell Res. 25, 496–516
11. Rub, U. et al. (2003) Thalamic involvement in a spinocerebellar
ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3)
patient, and its clinical relevance. Brain 126, 2257–2272
12. Gierga, K. et al. (2005) Involvement of the cranial nerves and their
nuclei in spinocerebellar ataxia type 2 (SCA2). Acta Neuropathol.
109, 617–631
13. Lastres-Becker, I. et al. (2016) Mammalian ataxin-2 modulates
translation control at the pre-initiation complex via PI3K/mTOR
and is induced by starvation. Biochim. Biophys. Acta 1862,
1558–1569
14. Swisher, K.D. and Parker, R. (2010) Localization to, and effects of
Pbp1, Pbp4, Lsm12, Dhh1, and Pab1 on stress granules in
Saccharomyces cerevisiae. PLoS One 5, e10006
15. Farg, M.A. et al. (2013) Ataxin-2 interacts with FUS and interme-
diate-length polyglutamine expansions enhance FUS-related
pathology in amyotrophic lateral sclerosis. Hum. Mol. Genet.
22, 717–728
16. Kim, H.J. et al. (2014) Therapeutic modulation of eIF2alpha phos-
phorylation rescues TDP-43 toxicity in amyotrophic lateral
sclerosis disease models. Nat. Genet. 46, 152–160
17. Figley, M.D. et al. (2014) Profilin 1 associates with stress granules
and ALS-linked mutations alter stress granule dynamics. J.
Neurosci. 34, 8083–8097
18. Elden, A.C. et al. (2010) Ataxin-2 intermediate-length polyglut-
amine expansions are associated with increased risk for ALS.
Nature 466, 1069–1075
19. Heck, M.V. et al. (2014) Dysregulated expression of lipid storage
and membrane dynamics factors in Tia1 knockout mouse
nervous tissue. Neurogenetics 15, 135–14420. Damrath, E. et al. (2012) ATXN2-CAG42 sequesters PABPC1
into insolubility and induces FBXW8 in cerebellum of old ataxic
knock-in mice. PLoS Genet. 8, e1002920
21. Li, Y.R. et al. (2013) Stress granules as crucibles of ALS
pathogenesis. J. Cell Biol. 201, 361–372
22. Kaehler, C. et al. (2012) Ataxin-2-like is a regulator of stress
granules and processing bodies. PLoS One 7, e50134
23. Kaehler, C. et al. (2015) PRMT1-mediated arginine methylation
controls ATXN2L localization. Exp. Cell Res. 334, 114–125
24. Shibata, H. et al. (2000) A novel protein with RNA-binding motifs
interacts with ataxin-2. Hum. Mol. Genet. 9, 1303–1313
25. Figueroa, K.P. and Pulst, S.M. (2003) Identification and
expression of the gene for human ataxin-2-related protein on
chromosome 16. Exp. Neurol. 184, 669–678
26. Ciosk, R. et al. (2004) ATX-2, the C. elegans ortholog of ataxin 2,
functions in translational regulation in the germline. Development
131, 4831–4841
27. Satterfield, T.F. et al. (2002) ADrosophila homolog of the polyglut-
amine disease gene SCA2 is a dosage-sensitive regulator of actin
filament formation. Genetics 162, 1687–1702
28. Zhang, Y. et al. (2013) A role for Drosophila ATX2 in activation
of PER translation and circadian behavior. Science 340,
879–882
29. Lim, C. and Allada, R. (2013) ATAXIN-2 activates PERIOD
translation to sustain circadian rhythms in Drosophila. Science
340, 875–879
30. Lee, J. et al. (2017) LSM12 and ME31B/DDX6 define distinct
modes of posttranscriptional regulation by ATAXIN-2 protein
complex in Drosophila circadian pacemaker neurons. Mol. Cell.
66, 129–140 e7
31. Pfeffer, M. et al. (2017) Impact of Ataxin-2 knock out on circadian
locomotor behavior and PER immunoreaction in the SCN of mice.
Chronobiol. Int. 34, 129–137
32. Fittschen, M. et al. (2015) Genetic ablation of ataxin-2 increases
several global translation factors in their transcript abundance but
decreases translation rate. Neurogenetics 16, 181–192
33. Mangus, D.A. et al. (1998) Pbp1p, a factor interacting with
Saccharomyces cerevisiae poly(A)-binding protein, regulates
polyadenylation. Mol. Cell. Biol. 18, 7383–7396
34. Bar, D.Z. et al. (2016) Cell size and fat content of dietary-restricted
Caenorhabditis elegans are regulated by ATX-2, an mTOR
repressor. Proc. Natl. Acad. Sci. U. S. A. 113, E4620–E4629
35. Wang, X. and Chen, X.J. (2015) A cytosolic network suppressing
mitochondria-mediated proteostatic stress and cell death.Nature
524, 481–484
36. Sudhakaran, I.P. et al. (2014) FMRP and Ataxin-2 function
together in long-term olfactory habituation and neuronal
translational control. Proc. Natl. Acad. Sci. U. S. A. 111,
E99–E108
37. Stubenvoll, M.D. et al. (2016) ATX-2, the C. elegans ortholog of
human Ataxin-2, regulates centrosome size and microtubule
dynamics. PLoS Genet. 12, e1006370
38. Gnazzo, M.M. et al. (2016) The RNA-binding protein ATX-2
regulates cytokinesis through PAR-5 and ZEN-4. Mol. Biol. Cell
27, 3052–3064
39. Kiehl, T.R. et al. (2001) Identification and expression of a mouse
ortholog of A2BP1. Mamm. Genome 12, 595–601Trends in Neurosciences, August 2017, Vol. 40, No. 8 515
40. Gehman, L.T. et al. (2011) The splicing regulator Rbfox1 (A2BP1)
controls neuronal excitation in the mammalian brain. Nat. Genet.
43, 706–711
41. Voineagu, I. et al. (2011) Transcriptomic analysis of autistic brain
reveals convergent molecular pathology. Nature 474, 380–384
42. Ayache, J. et al. (2015) P-body assembly requires DDX6 repres-
sion complexes rather than decay or Ataxin2/2L complexes.Mol.
Biol. Cell 26, 2579–2595
43. McCann, C. et al. (2011) The Ataxin-2 protein is required for
microRNA function and synapse-specific long-term olfactory
habituation. Proc. Natl. Acad. Sci. U. S. A. 108, E655–E662
44. Takahara, T. and Maeda, T. (2012) Transient sequestration of
TORC1 into stress granules during heat stress. Mol. Cell 47,
242–252
45. DeMille, D. et al. (2015) PAS kinase is activated by direct SNF1-
dependent phosphorylation and mediates inhibition of TORC1
through the phosphorylation and activation of Pbp1. Mol. Biol.
Cell 26, 569–582
46. Asada, A. et al. (2014) Cyclin-dependent kinase 5 phosphorylates
and induces the degradation of ataxin-2. Neurosci. Lett. 563,
112–117
47. Sen, N.E. et al. (2016) Search for SCA2 blood RNA biomarkers
highlights Ataxin-2 as strong modifier of the mitochondrial factor
PINK1 levels. Neurobiol. Dis. 96, 115–126
48. Lastres-Becker, I. et al. (2008) Insulin receptor and lipid metabo-
lism pathology in ataxin-2 knock-out mice. Hum. Mol. Genet. 17,
1465–1481
49. Kimura, Y. and Irie, K. (2013) Pbp1 is involved in Ccr4- and Khd1-
mediated regulation of cell growth through association with
ribosomal proteins Rpl12a and Rpl12b. Eukaryot. Cell 12, 864–
874
50. Abraham, K.J. et al. (2016) Intersection of calorie restriction and
magnesium in the suppression of genome-destabilizing
RNA–DNA hybrids. Nucleic Acids Res. 44, 8870–8884
51. Vianna, M.C. et al. (2016) Drosophila ataxin-2 gene encodes two
differentially expressed isoforms and its function in larval fat body
is crucial for development of peripheral tissues. FEBS Open Bio.
6, 1040–1053
52. Halbach, M.V. et al. (2017) Atxn2 knockout and CAG42-knock-in
cerebellum shows similarly dysregulated expression in calcium
homeostasis pathway. Cerebellum 16, 68–81
53. Zhang, S. et al. (2017) Novel metabolic and physiological
functions of branched chain amino acids: a review. J. Anim. Sci.
Biotechnol 8, 10
54. Meierhofer, D. et al. (2016) Ataxin-2 (Atxn2)-knock-out mice show
branched chain amino acids and fatty acids pathway alterations.
Mol. Cell. Proteom. 15, 1728–1739
55. Seidel, G. et al. (2017) Quantitative global proteomics of yeast
PBP1 deletion mutants and their stress responses identifies
glucose metabolism, mitochondrial, and stress granule changes.
J. Proteome Res. 16, 504–515
56. Dunn, C.D. and Jensen, R.E. (2003) Suppression of a defect in
mitochondrial protein import identifies cytosolic proteins required
for viability of yeast cells lacking mitochondrial DNA. Genetics
165, 35–45
57. Gispert, S. et al. (2009) Parkinson phenotype in aged PINK1-
deficient mice is accompanied by progressive mitochondrial
dysfunction in absence of neurodegeneration. PLoS One 4,
e5777
58. Fuhrmann, N. et al. (2010) Solving a 50 year mystery of a missing
OPA1mutation: more insights from the first family diagnosed with
autosomal dominant optic atrophy. Mol. Neurodegener. 5, 25516 Trends in Neurosciences, August 2017, Vol. 40, No. 859. Kasumu, A.W. et al. (2012) Chronic suppression of inositol 1,4,5-
triphosphate receptor-mediated calcium signaling in cerebellar
Purkinje cells alleviates pathological phenotype in spinocerebellar
ataxia 2 mice. J. Neurosci. 32, 12786–12796
60. Scoles, D.R. et al. (2012) ETS1 regulates the expression of
ATXN2. Hum. Mol. Genet. 21, 5048–5065
61. Gispert, S. et al. (2012) The modulation of amyotrophic lateral
sclerosis risk by ataxin-2 intermediate polyglutamine expansions
is a specific effect. Neurobiol. Dis. 45, 356–361
62. Lahut, S. et al. (2012) ATXN2 and its neighbouring gene SH2B3
are associated with increased ALS risk in the Turkish population.
PLoS One 7, e42956
63. Schols, L. et al. (2015) No parkinsonism in SCA2 and SCA3
despite severe neurodegeneration of the dopaminergic substan-
tia nigra. Brain 138, 3316–3326
64. Yamashita, C. et al. (2014) Evaluation of polyglutamine repeats in
autosomal dominant Parkinson’s disease. Neurobiol. Aging 35,
1779. e17–e21
65. Auburger, G.W. (2012) Spinocerebellar ataxia type 2. Handb.
Clin. Neurol. 103, 423–436
66. Almaguer-Mederos, L.E. et al. (2013) Estimation of survival in
spinocerebellar ataxia type 2 Cuban patients. Clin. Genet. 83,
293–294
67. Velázquez-Pérez, L. et al. (2017) Corticomuscular coherence: a
novel tool to assess the pyramidal tract dysfunction in spinocer-
ebellar ataxia type 2. Cerebellum 16, 602–606
68. Velázquez-Pérez, L. et al. (2016) Abnormal corticospinal tract
function and motor cortex excitability in non-ataxic SCA2
mutation carriers: a TMS study. Clin. Neurophysiol. 127,
2713–2719
69. Auburger, G. et al. (2014) 12q24 locus association with type 1
diabetes: SH2B3 or ATXN2? World J. Diabetes 5, 316–327
70. Sebastiani, P. et al. (2012) Genetic signatures of exceptional
longevity in humans. PLoS One 7, e29848
71. Abdel-Aleem, A. and Zaki, M.S. (2008) Spinocerebellar ataxia
type 2 (SCA2) in an Egyptian family presenting with polyphagia
and marked CAG expansion in infancy. J. Neurol. 255, 413–419
72. Hu, F. et al. (2016) Hypothalamic roles of mTOR complex I:
integration of nutrient and hormone signals to regulate energy
homeostasis. Am. J. Physiol. Endocrinol. Metab. 310, E994–
E1002
73. Na, D. et al. (2013) NeuroGeM, a knowledgebase of genetic
modifiers in neurodegenerative diseases. BMC Med. Genom.
6, 52
74. Al-Ramahi, I. et al. (2007) dAtaxin-2 mediates expanded Ataxin-
1-induced neurodegeneration in a Drosophila model of SCA1.
PLoS Genet. 3, e234
75. Lessing, D. and Bonini, N.M. (2008) Polyglutamine genes interact
to modulate the severity and progression of neurodegeneration in
Drosophila. PLoS Biol. 6, e29
76. Shulman, J.M. and Feany, M.B. (2003) Genetic modifiers of
tauopathy in Drosophila. Genetics 165, 1233–1242
77. Becker, L.A. et al. (2017) Therapeutic reduction of ataxin 2
extends lifespan and reduces pathology in TDP-43 mice. Nature
544, 367–371
78. Scoles, D.R. et al. (2017) Antisense oligonucleotide therapy for
spinocerebellar ataxia type 2. Nature 544, 362–366
79. Wiedemeyer, R. et al. (2003) Ataxin-2 promotes apoptosis of
human neuroblastoma cells. Oncogene 22, 401–411
